Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: ACCELEVIR DIAGNOSTICS LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2020-06-01 to 2022-02-28
Current total value of award: $299975
Description: EO14042: THE OBJECTIVE OF THIS CONTRACT IS TO ADAPT THE IPDA FOR THE MEASUREMENT OF LATENT HIV-1 FOR INDIVIDUALS WITH HIV-1 VIRAL GENETIC SUBTYPE CRF-1_AE.